Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 30, 2001, for Wilson Greatbatch Technologies, Inc. (Note: The request metadata listed "Integer Holdings Corp," but the filing text identifies the registrant as Wilson Greatbatch Technologies, Inc.). The company operates in two segments: medical power sources (implantable devices) and commercial power sources (aerospace, oil/gas). The financial statements are unaudited.
Key Financial Metrics
| Metric | Q1 2001 | Q1 2000 |
|---|---|---|
| Revenues | $29.6 million | $23.2 million |
| Gross Profit | $14.0 million | $10.2 million |
| Gross Margin | 47% | 44% |
| Operating Expenses (SG&A + R&D) | $7.0 million | $5.1 million |
| Income from Continuing Operations | $2.9 million | ($0.4 million) loss |
| Extraordinary Loss (Debt Restructuring) | ($3.0 million) | $0 |
| Net Loss | ($0.1 million) | ($0.4 million) |
| Cash from Operations | $2.5 million | $4.6 million |
| Cash and Equivalents (End of Period) | $0.3 million | $2.5 million |
| Total Debt (Current + Long-Term) | $35.9 million | $34.0 million |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 28% year-over-year, driven by the inclusion of Battery Engineering, Inc. (BEI) acquired in August 2000 and growth in the commercial segment (up 200%).
- Profitability: Income from continuing operations improved from a $0.4 million loss to a $2.9 million profit, aided by higher gross margins and significantly reduced interest expense (down 82% to $0.7 million).
- Debt Restructuring: The company consummated a new $60 million credit facility ($40 million term loan, $20 million revolver) in January 2001. Proceeds were used to retire all prior senior and subordinated debt, resulting in a $3.0 million extraordinary loss (net of tax) due to write-offs and call premiums.
- Cash Flow: Operating cash flow decreased to $2.5 million from $4.6 million, primarily due to increased working capital requirements (higher accounts receivable and inventory) to support sales growth.
Guidance, Outlook, and Risks
- Capital Expenditures: Management expects 2001 capital expenditures to be approximately $8.2 million, with $2.9 million allocated to new product development.
- Liquidity: Management believes cash generated from operations will be sufficient for working capital and planned capital expenditures in the near term. The company maintains a $20 million revolving line of credit.
- Market Risk: A hypothetical 10% change in short-term interest rates could impact 2001 earnings by approximately $0.1 million due to variable-rate debt.
- Risks: Key risks include dependence on a limited number of customers, product obsolescence, pricing pressure, reliance on third-party suppliers, and regulatory changes in the healthcare industry.
Investor Verification Checklist
- Debt Covenants: Verify compliance with the new credit agreement's quarterly financial covenants related to EBITDA and leverage ratios.
- Working Capital Trends: Monitor the continued increase in accounts receivable and inventory to ensure they align with sales growth and do not signal collection or obsolescence issues.
- Segment Performance: Confirm the sustainability of the 200% growth in the commercial power sources segment, which was heavily influenced by the BEI acquisition and oil/gas market recovery.
- Interest Rate Exposure: Assess the impact of rising interest rates on the new variable-rate debt structure (Prime - 1.0% or LIBOR + 1.25%).